article thumbnail

Conducting Healthcare Investment Research with Expert Insights

Alpha Sense BI

Clinical Pipelines and Drug Developments – Assessing the pipeline of pharmaceutical and biotechnology companies by analyzing clinical trials to gauge the potential success of new drugs or therapies in development.

article thumbnail

Debunking 5 Popular Expert Network Myths

Alpha Sense BI

One AlphaSense customer has saved tens of thousands of dollars by using our AI-search technology to optimize their research at various pharmaceutical companies. However, newer evolutions of the expert network can streamline access to industry experts through innovative technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Weighing risk and reward with gen AI vendor selection

CIO

So the top questions that go beyond the usual due diligence that companies must ask when evaluating generative AI vendors have to with training data, copyright, added value, and model independence. That would give the smaller vendors time to innovate further, or give customers time to migrate. It would take six months to a year.”

Alliance 821
article thumbnail

5 ESG Investing Trends and Developments to Watch in 2023

Alpha Sense BI

Without an official system to check an organization’s commitment to its ESG policies, many shareholders and investors are doing their due diligence through fact-checking. timber, natural pharmaceuticals) and services (i.e., In fact, biodiversity attrition can also severely hinder a company’s bottom line.

Finance 98
article thumbnail

5 Ways Expert Insights Lead to Successful M&A

Alpha Sense BI

These intangible factors indicate that even the most exhaustive due diligence processes can still leave gaps in the M&A research process. Comprehensive Due Diligence Thorough due diligence on a target company is undeniably the cornerstone of successful M&A.

article thumbnail

AI in Biopharma: Use Cases and Considerations

Alpha Sense BI

From identifying potential drug candidates and optimizing molecular structures to streamlining clinical trial design and enhancing personalized medicine , this technology is driving unprecedented efficiency and innovation. The integration of these systems enhances operational efficiency, freeing scientists to focus on innovation.

article thumbnail

M&A in Healthcare: 2024 Outlook

Alpha Sense BI

This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. M&A will serve as an avenue for pharmaceutical companies and start-ups to continue making significant advancements in their respective fields.